GENERAL HEALTH INTRODUCING ENDOBARRIER The latest minimally invasive weight loss and type 2 diabetes treatment. With 25% of Australian adults categorised as obese and an additional 40% considered overweight, the number of people suffering with type 2 diabetes is also increasing at epidemic rates. Type 2 diabetes is caused by a combination of genetic and environmental factors, although the risk of developing type 2 diabetes greatly increases when lifestyle factors such as being overweight or obese come into play. In its early stages, type 2 diabetes can be managed through controlled diet and exercise, however, over time most people with type 2 diabetes will also require medication and insulin. Enter EndoBarrier. This brand new non-invasive, non-surgical treatment is providing a solution for patients struggling with weight, particularly those who have been unable to control their diabetes or lose weight with other medications or signifi cant lifestyle changes. The EndoBarrier is a liner that is inserted endoscopically through a small tube through the mouth under a light general anaesthetic. The procedure only takes around 30 minutes and there are no scars or incisions. The EndoBarrier is a day procedure so patients are discharged home shortly after. Creating a physical barrier between food the patient ingests and the duodenum/ proximal jejunum, the EndoBarrier means that the food bypasses the duodenum and stops the food interacting with enzymes and hormones in the intestines. This affects key hormones that are involved with insulin levels, glucose metabolism and satiety. In essence, the EndoBarrier creates a lining that aids in the treatment of type 2 diabetes through glycemic control and weight loss through hormonal interaction and reducing the feeling of hunger. As the fi rst non-surgical, non-pharmaceutical technique for treating type 2 diabetes and obesity, Dr Jordaan of the Surgical Weight Loss Centre is excited to announce he will be making the EndoBarrier available to his patients. “This type of treatment has never been available here before,” enthuses Dr Jordaan. “It’s very exciting because people who have been struggling to control their weight and/or diabetes through other methods now have a minimally invasive option at their disposal.” The EndoBarrier is suitable for patients with a BMI between 30 and 45, and promises a decrease in body weight without altering the anatomy, and can be easily removed at the end of the treatment period. pm For more information on the EndoBarrier procedure, visit www.surgicalweightlosscentre.com.au Pindara Magazine 22 Summer - Autumn | 2014
Pindara Private Hospital Magazine - Issue One
To see the actual publication please follow the link above